应用 |
An irreversible inhibitor of P2Y12. |
产品介绍 |
Clopidogrel Bisulfate是一种口服的,噻吩吡啶类抗血小板药物。 |
备注 |
Clopidogrel (Plavix) is an oral, thienopyridine class antiplatelet agent. |
生化机理 |
S-(+)-Clopidogrel Hydrogen Sulfate is the S enantiomer of clopidogrel and acts as a P2Y12 receptor inhibitor. Inhibition of this receptor stops the signal transduction cascade responsible for platelet aggregation. Inhibition of the P2Y12 receptor by clopidogrel is irreversible. |
别名 |
二硫酸氯吡格雷;氯吡格雷硫酸盐;(S)-(+)-(2-氯苯基)-6,7-二氢噻吩并[3,2-c]吡啶-5(4H)乙酸甲酯硫酸氢盐;硫酸氯吡格雷;(S)-(+)-氯吡格雷硫酸盐;(S)-(+)-Clopidogrel hydrogensulfate;(S)-(+)-Methyl 2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)-2-(2-chlorophenyl)acetate hydrogensulfate; ;(S)-(+)-Clopidogrel bisulfate;Methyl (S)-(+)-2-(2-Chlorophenyl)-2-[6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl]acetate Sulfate;(S)-(+)-Clopidogrel Sulfate;Plavix |